论文部分内容阅读
[目的]了解鞍山城区2008~2012年恶性肿瘤的发病情况,为制定恶性肿瘤的综合防治措施提供科学依据。[方法]收集鞍山市肿瘤登记处2008~2012年恶性肿瘤的发病资料,计算恶性肿瘤的发病率、标化发病率、年龄别发病率和构成比等指标。标化率采用2000年全国人口普查标准人口和Segi’s世界标准人口为标准。[结果]2008~2012年鞍山城区恶性肿瘤粗发病率为333.1/10万,中标率为200.7/10万,世标率为195.0/10万,截缩率(35~64岁)为326.7/10万,累积率(0~74岁)为21.8%。男性发病率高于女性(男性世标率为212.7/10万,女性世标率为180.4/10万)。男性恶性肿瘤发病前10位为肺、结直肠、肝、胃、食管、膀胱、胰腺、肾、脑和神经系统、前列腺,占全部恶性肿瘤的81.9%。女性恶性肿瘤发病前10位为乳腺、肺、结直肠、宫颈、肝、胃、卵巢、子宫体、胰腺、脑和神经系统,占全部恶性肿瘤的81.8%。[结论]肺癌、结直肠癌、乳腺癌、肝癌、胃癌、宫颈癌等是威胁鞍山市城区居民健康的主要恶性肿瘤,要积极控制危险因素,加强防控。
[Objective] To understand the incidence of malignant tumors in Anshan city from 2008 to 2012 and provide scientific evidence for the comprehensive prevention and treatment of malignant tumors. [Methods] The incidence of malignant tumors in Anshan Cancer Registry from 2008 to 2012 was collected to calculate the incidence of malignant tumors, standardized incidence, age-related morbidity and composition ratio. Standardization rate using the 2000 national census standard population and Segi’s world standard population as the standard. [Results] The gross incidence rate of malignant tumors in Anshan City from 2008 to 2012 was 333.1 / 100,000, the winning rate was 200.7 / 100,000, the world standard rate was 195.0 / 100,000 and the shrinkage rate (35-64) was 326.7 / 10 Million, the cumulative rate (0 to 74 years) was 21.8%. The incidence of males was higher than that of females (male standard rate was 212.7 / 100,000, female standard rate was 180.4 / 100,000). The top 10 male malignancies were lung, colorectal, liver, stomach, esophagus, bladder, pancreas, kidney, brain and nervous system, and prostate, accounting for 81.9% of all malignant tumors. The top 10 women with malignant tumors were breast, lung, colorectal, cervix, liver, stomach, ovary, uterus, pancreas, brain and nervous system, accounting for 81.8% of all malignant tumors. [Conclusion] Lung cancer, colorectal cancer, breast cancer, liver cancer, gastric cancer and cervical cancer are the major malignant tumors that threaten the health of urban residents in Anshan City. Active control of risk factors and prevention and control should be strengthened.